Current Neuro-Oncology
Volume
25 Number 23
15 December 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 23, 15 December
Nair SM, Sahu A, Prasad A, George AM, Goel A, Gupta T.
Unusual
Extra-Axial and Extracranial Recurrence in an IDH Mutant
Astrocytoma: A Case Report.
Indian
J Radiol Imaging. 2023 Dec 4;34(2):351-355. doi:
10.1055/s-0043-1777012. PMID:
38549893. Case report. ˍ
Sato Y, Deguchi S, Norose T, Oishi
T, Mitsuya K, Sugino T, Akiyama Y, Nagashima T, Urakami K, Shimoda
Y, Ohshima K, Hayashi N, Yamaguchi K.
An
autopsy case of primary gliosarcoma with multiple extracranial
metastases: pathology after administration of bevacizumab and
genetic profile.
Nagoya
J Med Sci. 2023 Dec 4;85(4):828-835∟.
doi: 10.18999/nagjms.85.4.828∟.
PMID: 38155632∟.
Case report. ˍ
Gatz SA, Harttrampf AC, Brard C,
Bautista F, Andre N, Abbou S, Rubino J, Rondof W, Deloger M,
Rübsam M, Marshall LV, Hubschmann D, Nebchi S, Aerts I,
Thebaud E, De Carli E, Defachelles AS, Paoletti X, Godin R, Miah
K, Mortimer PGS, Vassal G, Geoerger B.
Phase
I/II study of the WEE1 inhibitor adavosertib (AZD1775) in
combination with carboplatin in children with advanced
malignancies: Arm C of the AcSé-SMART trial.
Clin
Cancer Res. 2023 Dec 5∟.
doi: 10.1158/1078-0432.CCR-23-2959∟.
PMID: 38051741∟.
Interventional study˰ ˍ
Chen KT, Huang CY, Pai PC, Yang WC,
Tseng CK, Tsai HC, Li JC, Chuang CC, Hsu PW, Lee CC, Toh CH, Liu
HL, Wei KC.
Focused
ultrasound combined with radiotherapy for malignant brain tumor: a
preclinical and clinical study.
J
Neurooncol. 2023 Dec 7∟.
doi: 10.1007/s11060-023-04517-x∟.
PMID: 38060066∟.
Laboratory investigation, Interventional study˰ ˍ
Lee IY, Hanft S, Schulder M, Judy
KD, Wong ET, Elder JB, Evans LT, Zuccarello M, Wu J, Aulakh S,
Agarwal V, Ramakrishna R, Gill BJ, Quiñones-Hinojosa A,
Brennan C, Zacharia BE, Silva Correia CE, Diwanji M, Pennock GK,
Scott C, Perez-Olle R, Andrews DW, Boockvar JA.
Autologous
cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide
in newly diagnosed glioblastoma patients.
Future
Oncol. 2023 Dec 7∟.
doi: 10.2217/fon-2023-0702∟.
PMID: 38060340∟.
Interventional study protocol. ˍ
Ruan J, Shi Y, Luo P, Li L, Huang
J, Chen J, Yang H.
Safety
and feasibility of intra-arterial delivery of teniposide to high
grade gliomas after blood-brain barrier disruption: a case
series.
J
Neurointerv Surg. 2023 Dec 7:jnis-2023-021055∟.
doi: 10.1136/jnis-2023-021055∟.
PMID: 38071559∟.
Case report. ˍ
Wilhelmy F, Gaier M, Planitzer U, Kasper J, Prasse G,
Frydrychowicz C, Oesemann R, Meixensberger J, Lindner D.
Venous
thromboembolism and intracranial hemorrhage in patients undergoing
glioblastoma surgery.
Sci
Rep. 2023 Dec 7;13(1):21679. doi:
10.1038/s41598-023-48542-2. PMID:
38066037. Observational study. ˍ
Erratum
in:
Sci
Rep. 2024
May 6;14(1):10352. doi:
10.1038/s41598-024-60939-1. PMID:
38710816 . Correction. ˍ
*
Auffret L, Ajlil Y,
Tauziède-Espariat A, Kergrohen T, Puiseux C, Riffaud L,
Blouin P, Bertozzi AI, Leblond P, Blomgren K, Froelich S, Picca A,
Touat M, Sanson M, Beccaria K, Blauwblomme T, Dangouloff-Ros V,
Boddaert N, Varlet P, Debily MA, Grill J, Castel D.
A
new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1
co-altered: a clinico-radiological and histomolecular
characterisation.
Acta
Neuropathol. 2023 Dec 8;147(1):2∟.
doi: 10.1007/s00401-023-02651-4∟.
PMID: 38066305∟.
Laboratory investigation. ˍ
Cherng HR, Sun K, Bentzen S,
Armstrong TS, Gondi V, Brown PD, Mehta M, Mishra MV.
Evaluating
the Heterogeneity of Hippocampal Avoidant Whole Brain Radiotherapy
Treatment Effect: A Secondary Analysis of NRG CC001.
Neuro
Oncol. 2023 Dec 9:noad226∟.
doi: 10.1093/neuonc/noad226∟.
PMID: 38069666∟.
Observational study˰ ˍ
Li X, Shao Y, Wang Z, Zhu J.
Risk
prediction and treatment assessment in glioma patients using SEER
database: a prospective observational study.
BMJ
Open. 2023 Dec 9;13(12):e079341∟. doi:
10.1136/bmjopen-2023-079341∟.
PMID: 38070919∟.
Observational study. ˍ
Takami H, Brown DA, Spear JA,
Shinya Y, Burns TC, Clarke MJ, Krauss WE.
Clinical
presentation, role of surgery and prognosis in spinal astrocytoma:
Cohort study.
World
Neurosurg X. 2023
Dec 9;21:100269. doi:
10.1016/j.wnsx.2023.100269. PMID:
38187503. Observational study. ˍ
*
Hadad S, Gupta R, Oberheim Bush NA,
Taylor JW, Villanueva-Meyer JE, Young JS, Wu
J, Ravindranathan A, Zhang Y, Warrier G, McCoy L, Shai A, Pekmezci
M, Perry A, Bollen AW,
Phillips JJ, Braunstein SE, Raleigh DR, Theodosopoulos P, Aghi MK,
Chang EF, Hervey-Jumper SL,
Costello JF, de Groot J, Butowski NA, Clarke JL, Chang
SM, Berger MS, Molinaro AM, Solomon DA.
"De
novo replication repair
deficient
glioblastoma, IDH-wildtype" is a distinct glioblastoma
subtype in adults
that may benefit from immune checkpoint blockade.
Acta
Neuropathol. 2023 Dec
11;147(1):3∟.
doi: 10.1007/s00401-023-02654-1∟.
PMID: 38079020∟.
Laboratory investigation, Case
report. ˍ
Sidaway P.
Tovorafenib
effective against low-grade gliomas harbouring BRAF fusions.
Nat
Rev Clin Oncol. 2023 Dec 11∟.
doi: 10.1038/s41571-023-00845-z∟.
PMID: 38082106∟.
News˰ ˍ
*
Cha J, Ding EA, Carvalho EM, Fowler
A, Aghi MK, Kumar S.
Glioma
Cells Secrete Collagen VI to Facilitate Invasion.
bioRxiv
[Preprint]. 2023 Dec
12:2023.12.12.571198. doi:
10.1101/2023.12.12.571198. PMID:
38168332. Laboratory investigation. ˍ
Kossmann MRP, Ehret F, Roohani S,
Winter SF, Ghadjar P, Acker G, Senger C, Schmid S, Zips D, Kaul
D.
Histopathologically
confirmed radiation-induced damage of the brain - an in-depth
analysis of radiation parameters and spatio-temporal
occurrence.
Radiat
Oncol. 2023 Dec 12;18(1):198∟.
doi: 10.1186/s13014-023-02385-3∟.
PMID: 38087368∟.
Observational study. ˍ
Bianconi A, Koumantakis E, Gatto A, Zeppa P, Saaid A, Nico E,
Bruno F, Pellerino A, Rizzo F, Junemann CV, Melcarne A, Garbossa
D, Dalmasso P, Cofano F.
Effects of
Levetiracetam and Lacosamide on survival and seizure control in
IDH-wild type glioblastoma during temozolomide plus radiation
adjuvant therapy.
Brain
Spine. 2023 Dec 14;4:102732. doi:
10.1016/j.bas.2023.102732. PMID:
38510602. Observational study. ˍ
*Pace A, Lombardi G, Villani V,
Benincasa D, Abbruzzese C, Cestonaro I, Corrà M, Padovan M,
Cerretti G, Caccese M, Silvani A, Gaviani P, Giannarelli D,
Ciliberto G, Paggi MG.
Efficacy
and safety of chlorpromazine as an adjuvant therapy for
glioblastoma in patients with unmethylated MGMT
gene
promoter: RACTAC, a phase II multicenter trial.
Front
Oncol. 2023 Dec
14;13:1320710. doi:
10.3389/fonc.2023.1320710. PMID:
38162492. Interventional study. ˍ
Sharma A, Garg A, Singh M, Sharma
MC, Gupta S, Kunhiparambath H, Tripathi M, Kale SS, Bal
C.
Metabolic
imaging in recurrent gliomas: comparative performance of
18F-FDOPA, 18F-fluorocholine and 18F-FDG PET/CT.
Nucl
Med Commun. 2023 Dec 14∟.
doi: 10.1097/MNM.0000000000001795∟.
PMID: 38095139∟.
Observational study˰ ˍ
Willems YCP, Vaassen F, Zegers CML,
Postma AA, Jaspers J, Romero AM, Unipan M, Swinnen A, Anten M,
Teernstra O, Compter I, van Elmpt W, Eekers DBP.
Anatomical
changes in resection cavity during brain radiotherapy.
J
Neurooncol. 2023 Dec 14∟.
doi: 10.1007/s11060-023-04505-1∟.
PMID: 38095775∟.
Observational study˰ ˍ
Dai L, Jing Z, Zhu Y, Deng K, Ma
L.
Genome-wide
analysis of circulating tumor
DNA
methylation profiles in cerebrospinal fluid: a clinical trial of
oncolytic virus
for glioblastoma.
Am
J Cancer Res.
2023 Dec 15;13(12):5950-5965. PMID:
38187045. Interventional study. ˍ